Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
复制标题
肿瘤微环境中癌症相关成纤维细胞和免疫细胞之间的串扰:新发现和未来前景。
DOI:
10.1186/s12943-021-01428-1
复制
发表时间:
2021-10-11
期刊:
影响因子:
37.3
通讯作者:
Shi S
中科院分区:
文献类型:
--
作者:
Mao X;Xu J;Wang W;Liang C;Hua J;Liu J;Zhang B;Meng Q;Yu X;Shi S
Cancer-associated fibroblasts (CAFs), a stromal cell population with cell-of-origin, phenotypic and functional heterogeneity, are the most essential components of the tumor microenvironment (TME). Through multiple pathways, activated CAFs can promote tumor growth, angiogenesis, invasion and metastasis, along with extracellular matrix (ECM) remodeling and even chemoresistance. Numerous previous studies have confirmed the critical role of the interaction between CAFs and tumor cells in tumorigenesis and development. However, recently, the mutual effects of CAFs and the tumor immune microenvironment (TIME) have been identified as another key factor in promoting tumor progression. The TIME mainly consists of distinct immune cell populations in tumor islets and is highly associated with the antitumor immunological state in the TME. CAFs interact with tumor-infiltrating immune cells as well as other immune components within the TIME via the secretion of various cytokines, growth factors, chemokines, exosomes and other effector molecules, consequently shaping an immunosuppressive TME that enables cancer cells to evade surveillance of the immune system. In-depth studies of CAFs and immune microenvironment interactions, particularly the complicated mechanisms connecting CAFs with immune cells, might provide novel strategies for subsequent targeted immunotherapies. Herein, we shed light on recent advances regarding the direct and indirect crosstalk between CAFs and infiltrating immune cells and further summarize the possible immunoinhibitory mechanisms induced by CAFs in the TME. In addition, we present current related CAF-targeting immunotherapies and briefly describe some future perspectives on CAF research in the end.
登录
查看更多内容
DOI:
10.1073/pnas.1600363113
发表时间:
2016-07-05
影响因子:
11.1
作者:
Arina, Ainhoa;Idel, Christian;Schreiber, Hans
通讯作者:
Schreiber, Hans
影响因子:
10.3
作者:
Brennen, W. Nathaniel;Rosen, D. Marc;Denmeade, Samuel R.
通讯作者:
Denmeade, Samuel R.
影响因子:
7.7
作者:
Barrett RL;Puré E
通讯作者:
Puré E
DOI:
10.1039/c5ib00040h
发表时间:
2015-10
期刊:
Integrative biology : quantitative biosciences from nano to macro
影响因子:
--
作者:
Acerbi I;Cassereau L;Dean I;Shi Q;Au A;Park C;Chen YY;Liphardt J;Hwang ES;Weaver VM
通讯作者:
Weaver VM
影响因子:
4.7
作者:
Bellone M;Calcinotto A
通讯作者:
Calcinotto A